Endocrinology (all articles)
Cohort Study | Associations of hypertriglyceridemia onset age with cardiovascular disease and all‐cause mortality in adults.
20 Oct, 2022 | 12:25h | UTC
Cross-sectional study | Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.
20 Oct, 2022 | 12:22h | UTC
Commentary on Twitter
The Lp(a) Heritage study, in prep for Lp(a) HORIZON, is now out- 48,129 pts eligible otherwise for Lp(a) HORIZON, with survey of Lp(a) levels. Data shows a higher prevalence of ⏫levels in pts with ASCVD vs general population at >70 mg/dL/>150 nmol/L https://t.co/lcp0gSLhCJ pic.twitter.com/DBGBNk0SOa
— Sam Tsimikas, MD (@Lpa_Doc) October 18, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ license
RCT | Combination of pitavastatin and ezetimibe vs. monotherapy of pitavastatin in patients with primary hypercholesterolemia.
19 Oct, 2022 | 14:15h | UTC
M-A | Safety of sotagliflozin in diabetes mellitus type 1 and type 2.
19 Oct, 2022 | 14:12h | UTC
M-A | Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes.
19 Oct, 2022 | 14:11h | UTC
Retrospective Cohort Study | Trends in the association between diabetes and cardiovascular events, 1994-2019.
18 Oct, 2022 | 12:58h | UTCTrends in the Association Between Diabetes and Cardiovascular Events, 1994-2019 – JAMA (free for a limited period)
Related Study: Study shows that the leading causes of hospitalization of adults with diabetes are changing.
RCT | Two-year effects of Semaglutide in adults with overweight or obesity.
18 Oct, 2022 | 12:53h | UTCCommentary: STEP 5: Sustained semaglutide treatment maintains weight loss – medwire News
Related:
RCT: Effect of high-dose subcutaneous Semaglutide vs. placebo in adults with overweight or obesity
Commentary on Twitter
Results from the STEP 5, testing #semaglutide as an adjuct to behavioral interventions in adults with #overweight or #obesity, demonstrate sustained #weightloss over a period of 104 weeks. @ProfBatterhamMD @seanwharton @DrGeorgiaRigas https://t.co/0mBtzhCYID
— Nature Medicine (@NatureMedicine) October 11, 2022
Perspective | The polypill: from concept and evidence to implementation.
18 Oct, 2022 | 12:55h | UTCThe polypill: from concept and evidence to implementation – The Lancet (free registration required)
Related:
Opinion: A new important study supports wider use of the polypill
Perspective: Are Polypills and Population-based Treatment the Next Big Things?
The Polypill Revisited: Why We Still Need Population-Based Approaches in the Precision Medicine Era
Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population
Perspective: The Polypill and the Long Journey to Major Impact
Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care
Position Statement | Changing the name of diabetes insipidus.
18 Oct, 2022 | 12:50h | UTC
M-A | Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome.
18 Oct, 2022 | 12:37h | UTC
Cluster RCT | Culturally sensitive vs. standard behavioral approach for promoting weight-loss maintenance in black women.
14 Oct, 2022 | 14:04h | UTC
Cohort Study | Duration of diabetes and use of insulin are the most important predictors of diabetic retinopathy.
13 Oct, 2022 | 13:44h | UTCCommentary: Insulin Use May Predict the Development of Diabetic Retinopathy – HCP Live
Systematic Review | Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.
13 Oct, 2022 | 13:39h | UTCSummary: Which hormonal therapy works better for women with early failure of the ovaries? – Cochrane Library
Commentary on Twitter
What is the best combination of #hormones that would allow women to have a baby after they suffered from early failure of the ovaries?
Based on limited #evidence from 3 small studies, we were unable to draw any clear conclusions https://t.co/krgfRi9VT3@CochraneLibrary pic.twitter.com/o9dN96E2zP
— Cochrane Gynaecology & Fertility (@CochraneCGF) October 7, 2022
Cohort Study | Effect of diabetes on morbidity and mortality in patients with acromegaly.
13 Oct, 2022 | 13:37h | UTC
Commentary on Twitter
Take a look at our new paper in JCEM that further our understanding about diabetes in patients with acromegaly. We show that concomitant diabetes in acromegaly is associated with an added mortality and morbidity risk https://t.co/2OIM0h1WzP #acromegaly #diabetes @EndoSocJournals pic.twitter.com/nOZIpARZwO
— Dr Daniel S. Olsson (@olsson_dr) July 3, 2022
Calculator | Estimating individual lifetime risk of cardiovascular events in adults with type 2 diabetes.
11 Oct, 2022 | 13:29h | UTCSee also: DIAL Model Calculator
Diabetic kidney disease back in focus: management field guide for health care professionals in the 21st century.
7 Oct, 2022 | 14:08h | UTCRelated: ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.
EASD/ADA Consensus Report | Automated insulin delivery: benefits, challenges, and recommendations.
6 Oct, 2022 | 13:46h | UTCAutomated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association – Diabetologia (if the link is paywalled, try this one)
Systematic Review | There is little evidence on pharmacological interventions to prevent weight gain in people with schizophrenia.
6 Oct, 2022 | 13:39h | UTC
ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.
5 Oct, 2022 | 13:59h | UTCNews Release: NEWS RELEASE: ADA & KDIGO Release Joint Consensus Report on Diabetes Management in CKD
Expert consensus | Glycemic management of critically ill patients.
4 Oct, 2022 | 14:38h | UTCRelated: Review | Glycemic control in the critically ill: Less is more.
Cohort Study | Diabetes diagnosed at younger ages is associated with increased morbidity compared to diagnosis in older adults.
3 Oct, 2022 | 14:02h | UTC
Guideline | Operative management of acute abdomen after bariatric surgery in the emergency setting.
3 Oct, 2022 | 13:59h | UTC
RCT | Doxycycline vs. placebo in patients with mild thyroid-associated ophthalmopathy.
30 Sep, 2022 | 12:35h | UTCDoxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)
Invited commentary: Oral Doxycycline for Mild Thyroid Eye Disease – JAMA Opthalmology (free for a limited period)
RCT | In patients with Type 1 Diabetes, the use of a “bionic pancreas” reduced HbA1c without increasing hypoglycemia.
29 Sep, 2022 | 13:35h | UTCMulticenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Cohort Study | Association between dairy intake and risk of CV disease and mortality in patients with stable angina pectoris.
28 Sep, 2022 | 13:38h | UTC